30 likes | 41 Views
Global capecitabine market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2019u20132026.
E N D
Capecitabine: Side Effects, Dosages, Treatment, Interactions… Capecitabine, sold below the brand name Xeloda among others, is a chemotherapy medication utilized to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often utilized composed with docetaxel.It is taken by mouth. Common side effects contain abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects contain blood clotting problems, allergic reactions, heart problems such as cardiomyopathy, and low blood cell counts. It is not suggested in people with kidney problems. Use during pregnancy may effect in harm to the baby.Capecitabine, inside the body, is transformed to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications called as fluoropyrimidines, which also contains 5-fluorouracil and tegafur. Development in Capecitabine Market: Global Capecitabine Market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2019–2026. Competitive Landscape: Some of the major Companies in the Capecitabine Market are Fresenius SE & Co. KGaA, Genentech, Inc., Dr Reddy Laboratories Ltd., Cipla Inc., Accord Healthcare Ltd.,
F. Hoffmann-La Roche Ltd., Teva Pharma B.V., Sandoz Inc., Zentiva N.V., and Ranbaxy Laboratories Ltd. Segmental Insights Trends: The Capecitabine Market is Segmented By Applications and Drug Formulation. By Application Colon Cancer Rectal Cancer Breast Cancer Gastric Cancer By Drug Formulation Tablets Capsules Colon cancer is a kind of cancer that begins in the large intestine. The colon is the final portion of the digestive tract. Colon cancer naturally affects older adults, though it can happen at any age. It typically begins as small, noncancerous clumps of cells known polyps that form on the inside of the colon. Over time some of these polyps can become colon cancers. Regional Insights: Geographically, the Capecitabine Market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America Europe Asia Pacific The Middle East & Africa Get FREE Sample copy of Capecitabine Market @ https://straitsresearch.com/report/capecitabine-market/request-sample
About StraitsResearch: StraitsResearch, we have a tendency to alter our buyers to solve the quality of assorted industries through our marketing research & Consulting Services. Our reports area unit single-point solutions for businesses to grow, evolve, and mature. Our period information assortment strategies in conjunction with ability to trace quite a million high growth niche merchandise area unit aligned together with your aims. The elaborated and proprietary applied mathematics models employed by our analysts supply insights for creating right call within the shortest span of your time. For organizations that need specific however comprehensive data we provide tailor-made solutions through adhoc reports. These requests area unit delivered with the right combination of right sense of fact-oriented downside finding methodologies and investment existing information repositories. Contact: Straits Research 825 3rd Avenue, New York, NY 10022. Phone Number:- +1 6464807505. Email: sales@straitsresearch.com. Website: https://straitsresearch.com/